NIDHI NARAYAN
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism HARRINGTON PARK, NJ NPI 1609073386
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NJ Amgen Inc. All categories
General Payments — all program years on this page
$13,338.57
- Category: General Payments
- Program years: PY2018–2024
- Record count: 951
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,504.34 across 96 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,504.34 | 96 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $300.76 | 26 |
| Corcept Therapeutics | $219.88 | 9 |
| Novo Nordisk AS | $205.13 | 14 |
| Lilly USA, LLC | $198.36 | 12 |
| Amneal Pharmaceuticals LLC | $67.59 | 4 |
| MannKind Corporation | $63.65 | 4 |
| Insulet Corporation | $58.10 | 3 |
| Abbott Laboratories | $48.91 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.61 | 3 |
| SANOFI-AVENTIS U.S. LLC | $47.15 | 3 |
| GlaxoSmithKline, LLC. | $46.07 | 3 |
| Xeris Pharmaceuticals, Inc. | $44.65 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $25.00 | 1 |
| Janssen Biotech, Inc. | $19.96 | 1 |
| Lundbeck LLC | $17.00 | 1 |
| ABBVIE INC. | $16.54 | 1 |
| Verity Pharmaceuticals Inc. | $16.26 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $16.05 | 1 |
| Kowa Pharmaceuticals America, Inc. | $15.82 | 1 |
| Amphastar Pharmaceuticals, Inc. | $15.30 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.55 | 1 |
By program year
Records — PY2024 (96)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.